{"id":"https://openalex.org/W2334427258","doi":"https://doi.org/10.1097/00002030-200212060-00020","title":"Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control","display_name":"Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control","publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W2334427258","doi":"https://doi.org/10.1097/00002030-200212060-00020","mag":"2334427258","pmid":"https://pubmed.ncbi.nlm.nih.gov/12461429"},"language":"en","primary_location":{"id":"doi:10.1097/00002030-200212060-00020","doi":"https://doi.org/10.1097/00002030-200212060-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200212060-00020","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018068497","display_name":"Don\u00a0E. Smith","orcid":"https://orcid.org/0000-0002-1308-4595","observed_orcids":["https://orcid.org/0000-0002-1308-4595"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Don E Smith","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112161317","display_name":"Andrew D Carr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Carr","raw_affiliation_strings":["HIV, Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, Au Australia;","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV, Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, Au Australia;","institution_ids":["https://openalex.org/I4210087284"]},{"raw_affiliation_string":"Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079993549","display_name":"Matthew G. Law","orcid":"https://orcid.org/0000-0002-3540-8837","observed_orcids":["https://orcid.org/0000-0002-3540-8837"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Matthew Law","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia;","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003501152","display_name":"Allison M. Martin","orcid":"https://orcid.org/0000-0001-6065-1188","observed_orcids":["https://orcid.org/0000-0001-6065-1188"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Allison Martin","raw_affiliation_strings":["National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia;","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079064453","display_name":"Jeff Hudson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff Hudson","raw_affiliation_strings":["AIDS Research Initiative, Sydney, Australia; and","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AIDS Research Initiative, Sydney, Australia; and","institution_ids":[]},{"raw_affiliation_string":"Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068114811","display_name":"Jennifer Hoy","orcid":"https://orcid.org/0000-0002-6948-7086","observed_orcids":["https://orcid.org/0000-0002-6948-7086"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jennifer Hoy","raw_affiliation_strings":["The Alfred Hospital, Department of Medicine, Monash University, Melbourne, Australia","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Alfred Hospital, Department of Medicine, Monash University, Melbourne, Australia","institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I56590836"]},{"raw_affiliation_string":"Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107834622","display_name":"David A. Cooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David A Cooper","raw_affiliation_strings":["HIV, Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, Au Australia;","National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia;","Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV, Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, Au Australia;","institution_ids":["https://openalex.org/I4210087284"]},{"raw_affiliation_string":"National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia;","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"Australia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6013,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.9117105,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"18","first_page":"2489","last_page":"2491"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9049999713897705},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/lipodystrophy","display_name":"lipodystrophy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.4449999928474426},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.49300000071525574},{"id":"https://openalex.org/keywords/body-fat-distribution","display_name":"body fat distribution","score":0.3790000081062317},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.7350000143051147},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.8854024410247803},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.8566131591796875},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.8456874489784241},{"id":"https://openalex.org/C2779546735","wikidata":"https://www.wikidata.org/wiki/Q3500973","display_name":"Lipoatrophy","level":5,"score":0.7943377494812012},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5953528881072998},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.5850905179977417},{"id":"https://openalex.org/C2779764123","wikidata":"https://www.wikidata.org/wiki/Q7972881","display_name":"Wasting","level":2,"score":0.5608052015304565},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.5064612627029419},{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.5064219236373901},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48485884070396423},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.4723927676677704},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.45357903838157654},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.43691107630729675},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.433030366897583},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.42879718542099},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.4287112355232239},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.42787009477615356},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4155747890472412},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38914814591407776},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.29149508476257324},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26763391494750977},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.1911253035068512},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.16391319036483765},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.14745324850082397},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.14400634169578552},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.13539743423461914},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D039682","descriptor_name":"HIV-Associated Lipodystrophy Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002030-200212060-00020","doi":"https://doi.org/10.1097/00002030-200212060-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002030-200212060-00020","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:12461429","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12461429","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1978724449","https://openalex.org/W2024720867","https://openalex.org/W2032425029","https://openalex.org/W2039681766","https://openalex.org/W2054385676","https://openalex.org/W2076459993","https://openalex.org/W2084332399","https://openalex.org/W2163492123","https://openalex.org/W2324473093"],"related_works":["https://openalex.org/W7099943976","https://openalex.org/W1965066662","https://openalex.org/W2103004284","https://openalex.org/W2133223036","https://openalex.org/W2088697089","https://openalex.org/W2042632827","https://openalex.org/W2165003108","https://openalex.org/W1918013950","https://openalex.org/W1997900349","https://openalex.org/W2030955068"],"abstract_inverted_index":{"Eighteen":[0],"patients":[1,198,390,709,720,851,868,977,1003,1069,1081],"with":[2,98,113,134,178,527,714,759,800,864,898,915,948,1070],"HIV":[3,841],"lipoatrophy,":[4],"receiving":[5,407],"quadruple":[6,206,236,980],"reverse":[7,115,207,237,889,900],"transcriptase-inhibitor":[8],"therapy":[9,20,74,112,210,856,981],"including":[10,892],"stavudine":[11,383,912],"or":[12,21,173,286,384,913],"zidovudine,":[13],"were":[14,92,132,246,276,332,343,373,406,589,775,818],"randomly":[15,277,374],"assigned":[16,278,375],"to":[17,95,155,189,248,279,376,381,560,567,630,636,778,785,852,854,888,958,996,1022,1091,1095,1104],"continue":[18,38,377,389,448,458,529,650,682,719,789],"current":[19,252,283,962],"stop":[22,34,44,450,460,524,551,647,686,708,806,1039],"stavudine/zidovudine.":[23],"After":[24],"24":[25,304,506,579,689,700,797,934],"weeks":[26,225,335,503,644,730,935,1030],"more":[27,222,242],"limb":[28,444,515,543],"fat":[29,126,147,190,302,310,445,516,544,604,673,988,998],"had":[30,200,220,429,1041],"recovered":[31],"in":[32,36,197,300,308,446,510,542,593,621,671,787,804,814,836,875,922,927,930,950,954,1001,1025],"the":[33,37,43,77,146,168,183,212,227,266,288,348,388,400,447,457,511,523,528,550,615,646,649,699,706,717,738,762,782,788,805,837,848,860,876,893,970,973,984,997,1009,1035,1038,1078],"than":[35,223,243,258,1060],"group;":[39],"however,":[40,937],"five":[41,704,763],"of":[42,51,72,109,150,159,170,186,226,291,357,387,424,513,705,716,761,793,840,850,871,883,895,911,942,960,972,986,1031,1037,1052,1075,1080],"subjects":[45,270,405,530,750,1040],"experienced":[46,710],"virological":[47,65],"failure.":[48],"The":[49,293,771,909,1100],"withdrawal":[50,196],"thymidine":[52,187,194,680,684,974,1063],"analogues":[53,188,944,975,1064],"from":[54,216,341,399,976],"a":[55,69,106,298,422,507,801,833,881,923,1050],"protease":[56,99,896],"inhibitor-sparing":[57],"regimen":[58],"can":[59,846,982],"improve":[60,786],"peripheral":[61,125,301,514,672,928,987],"fat,":[62],"but":[63,572,652,826,903,1004],"compromises":[64],"control.":[66],"Lipodystrophy":[67,831],"is":[68,83,153,176,832,964,1074],"well-recognized":[70],"side-effect":[71],"antiretroviral":[73,1044,1097],"[1],":[75],"although":[76],"precise":[78],"mechanism(s)":[79],"underlying":[80],"this":[81,151,361,890,1073,1088],"process":[82],"(are)":[84],"still":[85],"uncertain.":[86],"When":[87],"these":[88,993],"body":[89,309],"shape":[90],"changes":[91,307,1024],"initially":[93],"hypothesized":[94],"be":[96,364,946],"associated":[97,177,863],"inhibitor":[100,209,239],"(PI)":[101],"therapies":[102],"[2],":[103],"we":[104,192],"undertook":[105],"randomized":[107],"study":[108,122,230,267,295,702,816],"replacing":[110],"PI":[111],"alternative":[114],"transcriptase":[116,208,238,901],"inhibitors":[117,897],"(the":[118],"PILLR":[119],"study).":[120],"This":[121,990,1016],"revealed":[123],"that":[124,145,167,969,992],"wasting":[127,148,999],"actually":[128],"worsened":[129],"when":[130],"PIs":[131],"replaced":[133],"abacavir,":[135,408],"nevirapine,":[136],"adefovir":[137],"and":[138,231,268,315,321,324,328,338,378,395,418,438,442,449,459,495,505,602,660,735,751,843,1110,1115],"hydroxyurea":[139,416],"[3].":[140],"Others":[141],"have":[142,165,885,904,967,1018],"subsequently":[143],"suggested":[144,166],"component":[149,290],"condition":[152,1089],"related":[154],"nucleoside":[156,943],"analogue":[157,195,681,685],"impairment":[158],"mitochondrial":[160],"function":[161],"[4].":[162],"Observational":[163],"cohorts":[164],"duration":[169],"either":[171,594],"zidovudine":[172,914],"stavudine-containing":[174],"combinations":[175],"lipoatrophy":[179,431,929],"[5,6].":[180],"To":[181,879],"explore":[182],"possible":[184],"contribution":[185],"wasting,":[191],"evaluated":[193],"who":[199,219],"remained":[201,232],"virologically":[202],"controlled":[203],"on":[204,233,281,435,519,978,1011],"PI-sparing":[205,284,979],"within":[211],"PIILR":[213,229],"study.":[214,739],"Subjects":[215],"two":[217,744,749,931],"sites":[218],"completed":[221],"48":[224],"original":[228],"their":[234,251,282,961,1043,1053],"PI-sparing,":[235],"regimens":[240,1045],"for":[241,421,456,522,549,645,743,748,756,821,1067,1113],"6":[244],"months":[245],"approached":[247],"participate":[249],"if":[250],"plasma":[253,329],"viral":[254,711,766,1054],"load":[255],"was":[256,297,396,517,546,573,625,741],"less":[257],"400":[259],"copies/ml.":[260],"Participating":[261],"institutional":[262],"ethics":[263],"committees":[264],"approved":[265],"all":[269,404,815],"gave":[271],"written":[272],"informed":[273],"consent.":[274],"Patients":[275],"remain":[280],"therapy,":[285],"cease":[287,382],"zidovudine/stavudine":[289],"therapy.":[292,1015],"primary":[294],"endpoint":[296],"change":[299,792,803],"after":[303,393,933,1046],"weeks.":[305,690],"Regional":[306],"[dual-energy":[311],"X-ray":[312,676,693],"absorptiometry":[313,677],"(DEXA)":[314],"computed":[316,611],"tomography],":[317],"fasting":[318,622],"lipid,":[319],"metabolic":[320,454,861],"glycaemic":[322],"parameters,":[323,617],"CD4":[325,772],"lymphocyte":[326],"counts":[327,774],"HIV-RNA":[330],"levels":[331,605,624,662],"assessed":[333,609],"at":[334,432,553,577,642,654,729,869],"0,":[336],"12":[337,504,555,643,736,1029,1047],"24.":[339,656,770],"Differences":[340,813],"baseline":[342,403,822],"compared":[344,526,713,799],"between":[345,606,667,679,781,824],"groups":[346,428,461,687],"using":[347],"Mann\u2013Whitney":[349],"test.":[350],"Median":[351],"values":[352],"are":[353,1065,1084],"shown":[354],"throughout.":[355],"Because":[356],"limited":[358],"patient":[359,1010,1117],"numbers":[360],"analysis":[362],"should":[363],"considered":[365],"as":[366,409,411,608,1034,1049,1087],"exploratory.":[367],"Ten":[368],"men":[369,380],"(median":[370,791],"47":[371],"years)":[372],"nine":[379,707,718],"zidovudine.":[385],"One":[386],"moved":[391],"interstate":[392],"randomization,":[394],"therefore":[397],"excluded":[398],"analysis.":[401],"At":[402,502],"well":[410],"stavudine/zidovudine":[412],"(16/2),":[413],"nevirapine/efavirenz":[414],"(17/1),":[415],"(2)":[417],"lamivudine/didanosine":[419],"(17/1)":[420],"median":[423],"21.5":[425],"months.":[426],"Both":[427],"severe":[430],"baseline,":[433],"based":[434],"clinical":[436],"assessment":[437],"DEXA":[439,520],"scans":[440],"(7.5":[441],"6.7%":[443],"groups,":[451,607,825],"respectively).":[452],"Baseline":[453],"parameters":[455,817],"were:":[462],"triglycerides":[463],"2.2":[464],"versus":[465,471,476,482,487,492,498,532,562,582,632,648,683],"3.1":[466,493],"mmol/l,":[467,473,478,484,489,494,638],"total":[468],"cholesterol":[469],"5.1":[470],"6.5":[472],"HDL":[474],"0.9":[475,477],"LDL":[479],"(calculated)":[480],"3.0":[481,491],"3.15":[483],"lactate":[485,659],"1.7":[486],"1.3":[488],"C-peptide":[490,661],"insulin":[496],"13.9":[497],"10.7":[499],"mIU/l,":[500],"respectively.":[501],"significant":[508,540,576,591,925],"improvement":[509,541,620,926],"percentage":[512],"noted":[518,548,626,777,1000],"scanning":[521],"subjects,":[525,745],"(+0.65":[531],"\u22120.1%,":[533],"P":[534,569,585,639,810],"=":[535,570,586,640,722,811],"0.033)":[536],"(Fig.":[537],"1).":[538],"A":[539],"mass":[545],"only":[547,618,1012],"group":[552,790,807],"week":[554,578,655,701,769],"[+0.20":[556],"kg":[557,564,581],"(range":[558,565,628,634],"\u22120.25":[559],"+0.62)":[561],"\u22120.24":[563],"\u22120.60":[566],"+0.17),":[568],"0.008],":[571],"no":[574,590],"longer":[575],"(+0.27":[580],"\u22120.04":[583],"kg,":[584],"0.068).":[587],"There":[588],"differences":[592,823],"visceral":[595],"adipose":[596,599],"tissue,":[597,600],"subcutaneous":[598],"liver":[601],"leg":[603],"by":[610,674,768],"tomography":[612],"scanning.":[613],"Of":[614],"lipid":[616],"an":[619],"triglyceride":[623],"[\u22121.1":[627],"\u221213.1":[629],"+0.1)":[631],"+0.5":[633],"\u22121.0":[635],"+3.2)":[637],"0.005]":[641],"group,":[651],"not":[653,665,905],"Fasting":[657],"insulin,":[658],"also":[663,776],"did":[664],"differ":[666,779],"groups.Fig.":[668],"1.:":[669],"Change":[670],"dual-energy":[675],"scanning,":[678],"over":[688,796],"DEXA,":[691],"Dual-energy":[692],"absorptiometry.":[694],"\u2015\u25c6\u2015":[695],"Continue;":[696],"\u2013\u2013\u25aa\u2013\u2013":[697],"stop.Over":[698],"period,":[703],"rebounds":[712],"none":[715],"(P":[721],"0.029,":[723],"Fisher's":[724],"exact":[725],"test).":[726],"These":[727],"occurred":[728],"5,":[731],"7,":[732],"8,":[733,734],"into":[737],"Stavudine":[740],"re-introduced":[742],"didanosine":[746],"added":[747,755],"saquinavir":[752],"plus":[753],"ritonavir":[754],"one":[757],"subject;":[758],"three":[760],"re-achieving":[764],"undetectable":[765],"loads":[767],"cell":[773],"significantly":[780],"groups;":[783],"continuing":[784],"+100":[794],"cells/\u03bcl":[795],"weeks)":[798],"minimal":[802],"(\u22121":[808],"cell/\u03bcl,":[809],"0.017).":[812],"re-analysed":[819],"adjusting":[820],"yielded":[827],"essentially":[828],"similar":[829],"results.":[830],"common":[834],"problem":[835],"long-term":[838],"management":[839,1057],"disease,":[842],"its":[844],"appearance":[845],"compromise":[847],"willingness":[849],"adhere":[853],"effective":[855],"[7].":[857],"More":[858],"ominously,":[859],"abnormalities":[862],"lipodystrophy":[865,1026,1083],"may":[866,1017],"place":[867],"risk":[870],"serious":[872],"cardiovascular":[873],"problems":[874],"future":[877],"[8].":[878],"date":[880],"range":[882],"strategies":[884],"been":[886,906],"undertaken":[887],"condition;":[891],"replacement":[894,910,941],"non-nucleoside":[899],"inhibitors,":[902],"successful":[907],"[3,9].":[908],"other":[916,1059],"nucleosides":[917],"(predominately":[918],"abacavir)":[919],"has":[920],"resulted":[921],"statistically":[924],"studies":[932],"[10,11];":[936],"removal":[938,971],"without":[939],"adequate":[940],"must":[945],"used":[947],"caution":[949],"heavily":[951,1085],"treatment-experienced":[952,1068],"patients,":[953],"whom":[955],"background":[956],"resistance":[957],"some":[959],"medications":[963],"likely.":[965],"We":[966],"found":[968],"stabilize":[983],"loss":[985],"stores.":[989],"suggests":[991],"drugs":[994],"contribute":[995],"treated":[1002],"withdrawing":[1005],"them":[1006],"risks":[1007],"leaving":[1008],"partially":[1013],"suppressive":[1014],"influenced":[1019],"our":[1020,1032],"ability":[1021],"detect":[1023],"markers":[1027],"beyond":[1028],"study,":[1033],"majority":[1036,1079],"modified":[1042],"weeks,":[1048],"result":[1051],"rebounds.":[1055],"Better":[1056],"options":[1058],"simply":[1061],"removing":[1062],"needed":[1066],"lipoatrophy.":[1071],"Unfortunately,":[1072],"relevance":[1076],"because":[1077],"experiencing":[1082],"pre-treated,":[1086],"seems":[1090],"follow":[1092],"prolonged":[1093],"exposure":[1094],"multiple":[1096],"agents.":[1098],"Acknowledgements":[1099],"authors":[1101],"would":[1102],"like":[1103],"thank":[1105],"Wendy":[1106],"Lee,":[1107],"Karen":[1108],"MacRae":[1109],"Claire":[1111],"McCormack":[1112],"collecting":[1114],"entering":[1116],"data.":[1118]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}